Developer docs
API playgroundTry for free, no card

Search company profiles

GenomeWeb

Full company profile

uuid00097on

Namestring
GenomeWeb
Legal namestring
GenomeWeb
Websiteurl
genomeweb.com
Company typeenum
Private
Founded yearint
1997
Descriptiontext

GenomicWeb is an independent, privately held online publisher founded in 1997 and headquartered in New York. It is operated as a business unit of Crain Communications Inc., a diversified B2B media company. The platform delivers daily news, analysis, and regulatory intelligence focused exclusively on the genetics, genomics, molecular diagnostics, and precision medicine sectors, organized across dedicated topic sections spanning business and policy, sequencing and other technologies, basic research, diagnostics, disease areas (oncology, infectious disease, rare disease, reproductive health, COVID-19), and applied markets. Sister publications 360Dx and Precision Medicine Online extend coverage into molecular diagnostics and precision medicine respectively, with shared audiences and cross-promotion within the Crain portfolio. PMLS Events rounds out an events franchise.

The core product is a web-based content management and publishing platform with subscription-based paywall controls, supporting premium articles, premium newsletters, RSS feed syndication, sponsored webinars, and white papers. The technology stack is standard digital publishing infrastructure; there is no proprietary AI, software platform, diagnostic test, or laboratory technology developed or sold by GenomicWeb. The publication functions as an editorial intelligence layer for the life sciences industry rather than a technology vendor.

GenomicWeb makes money through three streams: (1) recurring subscription revenue from individuals and enterprise buyers (researchers, biotech/diagnostics executives, healthcare professionals), sold on annual contracts with pricing available only on request; (2) display advertising and sponsored content targeting the genetics/genomics professional community; and (3) sponsored webinars, virtual events, and white papers sold as mid-funnel lead-generation and employer-branding products. Customer segments are predominantly researchers and academics, biotech and diagnostics companies, and clinical/pathology professionals, addressed through vertical segmentation and content marketing across website, email newsletters, RSS, social, webinars, and white papers.

Short descriptiontext

GenomicWeb is a New York-based, privately held online B2B publisher operating as a business unit of Crain Communications. Founded in 1997, it delivers subscription-based news, analysis, and regulatory intelligence covering genetics, genomics, molecular diagnostics, and precision medicine to researchers, biotech executives, and clinical professionals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomics news, molecular diagnostics, precision medicine media, life sciences journalism, genetic research news
Industry3 codes
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
NAICS code1 code
  • Web Search Portals, Libraries, Archives, and Other Information Services5192
SIC code1 code
  • Periodicals: Publishing Or Publishing & Printing2721
Product category
Scientific News Publishing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Subscription Revenue
TypeSubscription Recurring
Description

Premium subscription model providing access to restricted content, analysis, and premium newsletters. Users can request annual quotes for subscriptions.

genomeweb.com
2Advertising and Sponsorships
TypeAdvertising
Description

Display advertising, sponsored content, and partnership opportunities targeting the genetics and genomics professional community.

genomeweb.com
3Webinars and Events
TypeProfessional Services
Description

Sponsored webinar content and virtual events for companies seeking to reach the professional audience.

genomeweb.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Premium Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Subscription pricing available upon request. Premium content includes exclusive analysis, reports, and newsletters.

genomeweb.com
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Brand1 of 2 records shown
1360Dx
Description

Sister publication focused on molecular diagnostics and precision medicine

genomeweb.com
+1 more record
Core offering1 text field

GenomeWeb is an online business-to-business news and information service covering the genetics and genomics industry, including molecular diagnostics, precision medicine, and life sciences research. It publishes original daily journalism, analysis, and curated news, distributed through a subscription website, email newsletters, and sister publications such as 360Dx and Precision Medicine Online.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

GenomeWeb is a genetics and genomics news and information service operated by Crain Communications. It provides subscription-based premium content including news articles, research coverage, regulatory updates, and industry intelligence across areas such as molecular diagnostics, sequencing technology, proteomics, drug discovery, and clinical genomics. The service operates several sister publications (360Dx, Precision Medicine Online) and offers content through web platforms, newsletters, RSS feeds, webinars, white papers, and job listings. GenomeWeb does not develop or sell software products, diagnostic tests, or technology platforms—it functions as a media and intelligence platform for the life sciences and diagnostics industries.

Product and service4 records
1GenomeWeb Premium Subscription
CategoryOnline news subscription
Description

Subscription access to GenomeWeb's daily news, in-depth features, and analysis on the genetics and genomics industry, targeted at researchers, clinicians, and industry professionals.

2360Dx
CategoryOnline news publication
Description

Sister publication covering news and analysis on the in vitro diagnostics industry, including regulatory, coverage, and reimbursement developments for diagnostic tests.

3Precision Medicine Online
CategoryOnline news publication
Description

Sister publication focused on precision medicine, covering clinical applications of genomic and molecular testing, targeted therapies, and patient care advances.

4GenomeWeb Email Newsletters
CategoryEmail newsletter
Description

Topic-specific email newsletters delivering curated genetics and genomics news, product announcements, and industry updates to subscribers.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthers
Description

Sister publication focused on molecular diagnostics providing complementary coverage and shared audience within the Crain Communications portfolio.

Strategic tierCoreTypeOthers
Description

Sister publication covering precision medicine topics with overlapping audience and cross-promotional opportunities within the genomics and diagnostics space.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BioSpace is a life sciences news and job-listing platform serving biotech, pharma, and diagnostics professionals with daily news, company profiles, and career content. Direct peer in audience and revenue mix (advertising + job listings + events).

TypeDirect peer
Description

STAT is a subscription-supported health and life sciences news outlet covering biotech, pharma, and policy. Direct peer in subscription paywall model and B2B-leaning audience of researchers, executives, and investors in life sciences.

TypeDirect peer
Description

Subscription-based B2B biopharma news outlet founded by journalists, with a similar paywalled analysis model. Direct peer in monetizing premium biotech/pharma intelligence through subscription, sponsored content, and events.

TypeEmerging player
Description

360Dx is GenomeWeb's sister publication under Crain Communications, focused specifically on molecular diagnostics. Highly comparable niche vertical, but smaller standalone footprint and owned by the same parent; serves as both internal synergy and adjacent competitor content.

TypeDirect peer
Description

Drug Discovery & Development covers pharma R&D and biotech research news and trends. Direct peer in serving life sciences R&D professionals with editorial coverage and sponsored content.

TypeDirect peer
Description

GEN is a long-running trade publication covering genetic engineering, biotechnology, and drug discovery. Closest direct competitor to GenomeWeb, serving overlapping audiences with similar news, analysis, and webinar offerings in the genomics/biotech space.

TypeDirect peer
Description

Fierce Biotech and Fierce Pharma are subscription-supported B2B life sciences news outlets covering drug development, biotech deals, and regulatory news. Direct peer in audience (biotech/diagnostics professionals) and revenue model (subscription + advertising + events).

8Clinical OMICS
TypeDirect peer
Description

Clinical OMICS covers molecular diagnostics, genomics, and precision medicine news for clinicians and researchers. Direct peer targeting the diagnostics/genomics segment that is core to GenomeWeb's audience.

TypeBroad incumbent
Description

Citeline (formerly Pharma Intelligence) is a large, established pharma/life sciences intelligence provider under Informa, offering paid databases, news, and analytics. Broad incumbent that competes for the same healthcare professional intelligence budget as GenomeWeb, though at much larger scale and broader scope.

TypeEmerging player
Description

MedCity News covers healthcare innovation, digital health, and biotech business news with a B2B subscription-supported model. Emerging peer with overlapping biotech/diagnostics audience but broader healthcare coverage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GenomeWeb

Scientific News Publishinggenomeweb.com

GenomicWeb is a New York-based, privately held online B2B publisher operating as a business unit of Crain Communications. Founded in 1997, it delivers subscription-based news, analysis, and regulatory intelligence covering genetics, genomics, molecular diagnostics, and precision medicine to researchers, biotech executives, and clinical professionals.

What GenomeWeb does

GenomicWeb is an independent, privately held online publisher founded in 1997 and headquartered in New York. It is operated as a business unit of Crain Communications Inc., a diversified B2B media company. The platform delivers daily news, analysis, and regulatory intelligence focused exclusively on the genetics, genomics, molecular diagnostics, and precision medicine sectors, organized across dedicated topic sections spanning business and policy, sequencing and other technologies, basic research, diagnostics, disease areas (oncology, infectious disease, rare disease, reproductive health, COVID-19), and applied markets. Sister publications 360Dx and Precision Medicine Online extend coverage into molecular diagnostics and precision medicine respectively, with shared audiences and cross-promotion within the Crain portfolio. PMLS Events rounds out an events franchise.

The core product is a web-based content management and publishing platform with subscription-based paywall controls, supporting premium articles, premium newsletters, RSS feed syndication, sponsored webinars, and white papers. The technology stack is standard digital publishing infrastructure; there is no proprietary AI, software platform, diagnostic test, or laboratory technology developed or sold by GenomicWeb. The publication functions as an editorial intelligence layer for the life sciences industry rather than a technology vendor.

GenomicWeb makes money through three streams: (1) recurring subscription revenue from individuals and enterprise buyers (researchers, biotech/diagnostics executives, healthcare professionals), sold on annual contracts with pricing available only on request; (2) display advertising and sponsored content targeting the genetics/genomics professional community; and (3) sponsored webinars, virtual events, and white papers sold as mid-funnel lead-generation and employer-branding products. Customer segments are predominantly researchers and academics, biotech and diagnostics companies, and clinical/pathology professionals, addressed through vertical segmentation and content marketing across website, email newsletters, RSS, social, webinars, and white papers.

GenomeWeb firmographics

Firmographics
Name
GenomeWeb
Legal name
GenomeWeb
Website
https://genomeweb.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
11–50 employees
Short description
GenomicWeb is a New York-based, privately held online B2B publisher operating as a business unit of Crain Communications. Founded in 1997, it delivers subscription-based news, analysis, and regulatory intelligence covering genetics, genomics, molecular diagnostics, and precision medicine to researchers, biotech executives, and clinical professionals.
Ownership category
akta.pro rank

GenomeWeb industry classification

Industry
Product category
Scientific News Publishing
NAICS
Web Search Portals, Libraries, Archives, and Other Information Services (5192)
SIC
Periodicals: Publishing Or Publishing & Printing (2721)
akta.pro industry
PRIMARYHLAGANAA
Genomics & Next-Generation Sequencing (NGS) Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Keywords

  • Genomics news
  • Molecular diagnostics
  • Precision medicine media
  • Life sciences journalism
  • Genetic research news

Where GenomeWeb is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

GenomeWeb business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Subscription Revenue: Premium subscription model providing access to restricted content, analysis, and premium newsletters. Users can request annual quotes for subscriptions.
  2. Advertising and Sponsorships: Display advertising, sponsored content, and partnership opportunities targeting the genetics and genomics professional community.
  3. Webinars and Events: Sponsored webinar content and virtual events for companies seeking to reach the professional audience.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPremium Subscription

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

GenomeWeb product offering

Product offering

Core offering

GenomeWeb is an online business-to-business news and information service covering the genetics and genomics industry, including molecular diagnostics, precision medicine, and life sciences research. It publishes original daily journalism, analysis, and curated news, distributed through a subscription website, email newsletters, and sister publications such as 360Dx and Precision Medicine Online.

Product overview

GenomeWeb is a genetics and genomics news and information service operated by Crain Communications. It provides subscription-based premium content including news articles, research coverage, regulatory updates, and industry intelligence across areas such as molecular diagnostics, sequencing technology, proteomics, drug discovery, and clinical genomics. The service operates several sister publications (360Dx, Precision Medicine Online) and offers content through web platforms, newsletters, RSS feeds, webinars, white papers, and job listings. GenomeWeb does not develop or sell software products, diagnostic tests, or technology platforms—it functions as a media and intelligence platform for the life sciences and diagnostics industries.

Differentiator

Problem solved

Functional benefit

Brands

  • 360Dx: Sister publication focused on molecular diagnostics and precision medicine
  • Precision Medicine Online

Products and services

  • GenomeWeb Premium Subscription Subscription access to GenomeWeb's daily news, in-depth features, and analysis on the genetics and genomics industry, targeted at researchers, clinicians, and industry professionals.
  • 360Dx Sister publication covering news and analysis on the in vitro diagnostics industry, including regulatory, coverage, and reimbursement developments for diagnostic tests.
  • Precision Medicine Online Sister publication focused on precision medicine, covering clinical applications of genomic and molecular testing, targeted therapies, and patient care advances.
  • GenomeWeb Email Newsletters Topic-specific email newsletters delivering curated genetics and genomics news, product announcements, and industry updates to subscribers.

Companies that use GenomeWeb

Customer profile

Segments3 records

Ideal customer profiles3 records

GenomeWeb technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

GenomeWeb partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • 360DxcoreOthersSister publication focused on molecular diagnostics providing complementary coverage and shared audience within the Crain Communications portfolio.
  • Precision Medicine OnlinecoreOthersSister publication covering precision medicine topics with overlapping audience and cross-promotional opportunities within the genomics and diagnostics space.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

GenomeWeb competitors and assessment

Company assessment

Direct peers

  • BioSpace: BioSpace is a life sciences news and job-listing platform serving biotech, pharma, and diagnostics professionals with daily news, company profiles, and career content. Direct peer in audience and revenue mix (advertising + job listings + events).
  • STAT News: STAT is a subscription-supported health and life sciences news outlet covering biotech, pharma, and policy. Direct peer in subscription paywall model and B2B-leaning audience of researchers, executives, and investors in life sciences.
  • Endpoints News: Subscription-based B2B biopharma news outlet founded by journalists, with a similar paywalled analysis model. Direct peer in monetizing premium biotech/pharma intelligence through subscription, sponsored content, and events.
  • Drug Discovery & Development: Drug Discovery & Development covers pharma R&D and biotech research news and trends. Direct peer in serving life sciences R&D professionals with editorial coverage and sponsored content.
  • Genetic Engineering & Biotechnology News (GEN): GEN is a long-running trade publication covering genetic engineering, biotechnology, and drug discovery. Closest direct competitor to GenomeWeb, serving overlapping audiences with similar news, analysis, and webinar offerings in the genomics/biotech space.
  • Fierce Biotech / Fierce Pharma (Questex): Fierce Biotech and Fierce Pharma are subscription-supported B2B life sciences news outlets covering drug development, biotech deals, and regulatory news. Direct peer in audience (biotech/diagnostics professionals) and revenue model (subscription + advertising + events).
  • Clinical OMICS: Clinical OMICS covers molecular diagnostics, genomics, and precision medicine news for clinicians and researchers. Direct peer targeting the diagnostics/genomics segment that is core to GenomeWeb's audience.

Emerging players

  • 360Dx: 360Dx is GenomeWeb's sister publication under Crain Communications, focused specifically on molecular diagnostics. Highly comparable niche vertical, but smaller standalone footprint and owned by the same parent; serves as both internal synergy and adjacent competitor content.
  • MedCity News: MedCity News covers healthcare innovation, digital health, and biotech business news with a B2B subscription-supported model. Emerging peer with overlapping biotech/diagnostics audience but broader healthcare coverage.

Broad incumbents

  • Citeline / Informa Pharma Intelligence: Citeline (formerly Pharma Intelligence) is a large, established pharma/life sciences intelligence provider under Informa, offering paid databases, news, and analytics. Broad incumbent that competes for the same healthcare professional intelligence budget as GenomeWeb, though at much larger scale and broader scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

GenomeWeb social profiles

Digital presence

GenomeWeb financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GenomeWeb leadership team

Management profile

Number of profiles

Profiles1 record

GenomeWeb funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GenomeWeb M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenomeWeb

What does GenomeWeb do?

GenomeWeb is an online business-to-business news and information service covering the genetics and genomics industry, including molecular diagnostics, precision medicine, and life sciences research. It publishes original daily journalism, analysis, and curated news, distributed through a subscription website, email newsletters, and sister publications such as 360Dx and Precision Medicine Online.

Is GenomeWeb a public or private company?

GenomeWeb is a private company. It is classified as corporate owned and is currently operating.

When was GenomeWeb founded?

GenomeWeb was founded in 1997. It employs 11 to 50 people.

Where is GenomeWeb based?

GenomeWeb is headquartered in New York, United States, in the North America region.

How does GenomeWeb make money?

Three revenue lines are on record. Subscription Revenue is the primary driver. The others are advertising and Sponsorships and webinars and Events.

Who are GenomeWeb's main competitors?

Direct peers on record are BioSpace, STAT News, Endpoints News, Drug Discovery & Development, Genetic Engineering & Biotechnology News (GEN), Fierce Biotech / Fierce Pharma (Questex) and Clinical OMICS. Emerging players are 360Dx and MedCity News. Citeline / Informa Pharma Intelligence is listed as a broad incumbent.

Does GenomeWeb have an API?

No public API is recorded for GenomeWeb.

What industry is GenomeWeb in?

GenomeWeb's product category is Scientific News Publishing. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 5192 and its SIC code is 2721.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireLucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive YearLucid Diagnostics was named a GenomeWeb 2026 Best Place to Work for the second consecutive year, based on employee feedback. CEO Shaun O'Neil said the honor reflects the company's culture, and EsoGuard is now fully reimbursed by Medicare nationwide. The company plans to expand its team to accelerate commercialization.MorningstarLucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking HonoreeLucid Diagnostics was named the winner in its company size category of the GenomeWeb 2025 Best Places to Work program, one of five top-ranking honorees. The company, a cancer prevention diagnostics subsidiary of PAVmed, focuses on esophageal precancer detection via its EsoGuard test.PR NewswireVolition Sponsors Upcoming GenomeWeb WebinarVolitionRx Limited announced its sponsorship of a GenomeWeb webinar titled 'Beyond the Genome: Measuring Epigenetic Modifications Across Matrices for Biomarker and Drug Discovery' scheduled for October 8, 2025. The webinar will showcase Volition's Nu.Q® Discover service, featuring speakers Dr. Eric Ariazi and Dr. Marielle Herzog discussing epigenetic pathways, PRC2/EZH2/EED inhibitors for cancer treatment, and the application of Nu.Q assays in disease research and clinical development.Financial TimesGenomeWeb to host joint Agilent/OBD presentation – Company AnnouncementOxford BioDynamics will host a GenomeWeb webinar on its EpiSwitch 3D genomic platform, sponsored by Agilent, on 17 July. The platform's prostate cancer test (EpiSwitch PSE) boosts PSA predictive accuracy from 55% to 94%. The webinar will also cover a canine multi-cancer blood test.FinancialContent Business PageRenowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb WebinarChristopher Mason, Ph.D., of Weill Cornell Medicine will discuss his Two Frontiers Project and plans to use Quantum-Si's Platinum benchtop protein sequencer in a GenomeWeb webinar on February 28. The event will cover multiomic research on extremophiles and their relevance to human survival in extreme environments.PR NewswireFluent BioSciences Partners with GenomeWeb and NYU Grossman School of Medicine's Liddelow Lab to Host Webinar on Revolutionary PIPseq scRNA-Seq Technology with Upcoming bioRxiv PublicationFluent BioSciences announced a partnership with GenomeWeb and NYU Grossman School of Medicine's Liddelow Lab to host a webinar on May 18, 2023 about its PIPseq single-cell RNA sequencing technology. The Liddelow Lab has been using PIPseq for high-throughput single-cell analysis of central nervous system cells in mouse brain models and will present findings from an upcoming publication. Fluent BioSciences CEO Brian Mckernan highlighted the technology's scalability, cost-effectiveness, and high-throughput capabilities as key differentiators.PR NewswireCrain Communications Inc acquires online news organization GenomeWebCrain Communications Inc acquired GenomeWeb, an online news organization serving the global molecular biology research and diagnostics community, with the transaction officially completed on September 1, 2019. GenomeWeb, launched in 1997 and currently employing 30 people in New York, will join Crain's portfolio of business-to-business brands spanning sectors including healthcare, automotive, and technology. The acquisition was positioned as a strategic complement to Crain's existing media properties, with both companies citing the synergies in high-quality, independent business journalism.AdAgeCrain Communications acquires GenomeWebCrain Communications acquired GenomeWeb, an online news organization for scientists and molecular diagnostics professionals. The New York-based site, launched in 1997, covers genome sequencing and M&A, with 30 staff. The acquisition expands Crain's footprint in scientific media, complementing its existing brands.PR NewswirePioneering Survey of Clinical NGS QC Practices Proves Need for Purpose-Built QC Solutions to Standardize IndustrySeraCare Life Sciences partnered with GenomeWeb to conduct a survey of over 150 clinical NGS labs, revealing significant challenges in quality control standardization and reliance on homebrew solutions. The findings indicate that inconsistent QC practices lead to frequent troubleshooting delays, which can impact patient care by delaying reporting times. SeraCare aims to address these issues by promoting its Seraseq reference materials and iQ NGS QC Management software as standardized tools for the industry.PR NewswireStudy Finds Precision Medicine Initiatives Active in Broader Spectrum of Disease Areas and Datasets, But Not Without Technological ChallengesOracle Health Sciences announced results of a study conducted by GenomeWeb exploring the state of precision medicine initiatives, surveying 316 scientists and researchers from life sciences and healthcare organizations. The study found that 62 percent of respondents currently participate in precision medicine research, with oncology expected to have the greatest impact, though cardiovascular, neurology, and pediatrics are also growing areas; over 72 percent use next-generation sequencing variant panels. Technical infrastructure deficiencies were identified as the primary obstacle preventing organizations from fully leveraging larger, more complex datasets to improve treatment recommendations.